miR‐1307 is an important anti‐apoptotic oncoprotein, known to promote chemotherapy resistance in ovarian cancer by targeting ING5 expression, and miR‐1307 may be a therapeutic target for ovarian cancer.40 This evidence concerns the gene ING5 and ovarian carcinoma.